New Drug Application for hyperphosphatemia in chronic kidney disease patients on dialysis under review by the FDA with a ...

The off-label use of JAK inhibitors to treat JDM is common in pediatric rheumatology, with barriers to use including limited clinical trial data and insurance approval.

From 2011 to 2022, mental health inequities by age, sex, and racial and ethnic group, were large, fluctuated over time, and matched prior research.

Revvity has higher revenue and earnings than Nautilus Biotechnology. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more ...

Dozens of problematic papers remain in the literature, after a publication hit by fraudsters pledged to tackle the issue.

Even still, the pharma deals announced out of the event brought a clear message for the biotech industry. Technology ...

Implanted BCIs are electrodes put in paralyzed people’s brains so they can use imagined movements to send commands from their ...

China has captured production of portions of the global biotechnology supply chain to accomplish President Xi Jinping’s goal to “develop effective deterrent against attempts by other countries ...

For the biotech industry, 2024 meant the return of the venture capital megaround. And one startup, Xaira Therapeutics, took it a step further, expanding the industry’s definition of a megaround ...

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. This newsletter is gloomy ...

And like many other young players in the biotechnology business, this one's also still booking sizable losses, adding to investors' general disinterest. What this company lacks in size and profits ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...